American Journal of Obstetrics and Gynecology
ResearchGeneral gynecologyDisease expression in women with hereditary angioedema
Section snippets
Materials and Methods
A retrospective study was conducted. One hundred fifty postpubertal women were enrolled within the framework of the PREHAEAT Project (QLG1-CT-2002601359) of the European Union. The aim of this project was to improve the quality of life of patients with HAE. Hormonal problems in HAE were the subject of the Fifth Work Package of the Project. All women had a C1Inh functional level of 40% or lower, family or personal history of HAE, and/or mutation of the C1Inh gene.
A specific patient-based
Characteristics of the sample
Data of 150 postpubertal women from 8 countries: Hungary (32%), Germany (19%), Denmark (10%), France (10%), Spain (10%), Norway (8%), United Kingdom (6%), and Switzerland (5%), were analyzed. The average age of puberty was 13.5 years (range: 9-17 years). Forty-four women had undergone menopause at an average age of 48.5 years (range: 37-56 years). One hundred seven women had experienced 227 pregnancies.
Puberty and menstrual cycle: Influence on HAE course
Puberty worsened the disease for 62%; the remaining 38% percent of women reported no change.
Comment
This retrospective analysis answers frequently asked questions about puberty, fertility, pregnancies, and contraception in women with HAE. There is no increase in gynecologic events or infertility. Pregnancy is likely to worsen, improve, or to have no effect on disease severity equally. The observation4 that HAE symptoms improve during the 2 last trimesters was not confirmed in our study. Because of insufficient data, we could not answer the question whether HAE course during pregnancy is
References (44)
- et al.
Plasma bradykinin in angioedema
Lancet
(1998) - et al.
Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy
Am J Med
(2003) - et al.
Hereditary angioedema with normal C1 inhibitor activity in women
Lancet
(2000) - et al.
Clinical, biochemical, and genetic characterization of a novel estrogen dependent inherited form of angioedema
J Allergy Clin Immunol
(2000) - et al.
Hereditary angioedema type III: an additional pedigree with autosomal dominant transmission
J Allergy Clin Immunol
(2001) - et al.
Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor
Biochem Biophys Res Commun
(2006) - et al.
Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III
Am J Human Genet
(2006) - et al.
Activation of the coagulation cascade in C1-Inhibitor deficiencies
Blood
(1997) - et al.
Activation of factor XII and cleavage of high molecular weight kininogen during acute attacks in hereditary and acquired C1-inhibitor deficiencies
Immunopharmacology
(1996) - et al.
Interim results of EDEMA2, a multicenter, open-label, repeat-dosing study of intravenous and subcutaneous administration of ecallantide (DX-88) in hereditary angioedema
J Allergy Clin Immunol
(2006)
Estrogen induction and contact phase activation of human factor XII
Steroids
The influence of estrogen and prolactin on Hageman factor titer in ovariectomized and hypophysectomized rats
Blood
Differential regulation of kininogen gene expression by estrogen and progesterone in vivo
Biochim Biophys Acta
Contact activation factors in plasma from women using oral contraceptives increased levels of factor XII, kinin-free high molecular weight kininogen and acetone-activated kallikrein
Thromb Res
Estrogen associated thromboembolism
Ann Epidemiol
Positive impact of hormone replacement therapy on the fibrinolysis system: a long term randomized controlled study in healthy postmenopausal women
J Thromb Haemost
Contact activation factors in plamsa from women on estrogen replacement therapy after ovariohysterectomy
Thromb Res
Hereditary angioedema
N Engl J Med
Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant
Allergy
Hereditary angio-oedema: new clinical observations and autoimmune screening, complement and kallikrein-kinin analyses
J Intern Med
Hormonally exacerbated hereditary angioedema
Australas J Dermatol
Coexistence of hereditary angioedema and Turner's syndrome
Postgrad Med
Cited by (149)
The effect of estrogen-containing birth control pills on the constituents of bradykinin expression in plasma
2024, Journal of Allergy and Clinical Immunology: GlobalHereditary Angioedema: A Review of the Current and Evolving Treatment Landscape
2023, Journal of Allergy and Clinical Immunology: In PracticeHigh digit ratio (2D:4D) is associated with attack frequency and severity in hereditary angioedema patients
2023, Early Human DevelopmentTrends in Treatments With Disease-Specific and Interfering Drugs in Patients With Hereditary Angioedema in Sweden
2023, Journal of Allergy and Clinical Immunology: In PracticeHereditary Angioedema During Pregnancy: Considerations in Management
2023, Immunology and Allergy Clinics of North America
This project was performed within the framework of the PREHAEAT project (QLG1-CT-2002-01359) of the European Union and was supported by grants from the thematic action 5 of the French 2002 Programme Hospitalier de Recherche Clinique PHRC.
Cite this article as: Bouillet L, Longhurst H, Boccon-Gibod I, et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008;199:484.e1-484.e4.
Reprints not available from the authors.